Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA575954
Title Progenitor Cell Fate Decisions in Mammary Tumorigenesis.
Publication Date Mar 2013
Media Count 31p
Personal Author D. Crowe
Abstract We proposed that alterations in histone methylation regulate MSC fate commitment and predispose these progeny to malignant transformation. Transformed ER+ epithelial cells deregulate proliferation of MSC and luminal progenitors contributing to transformation of ER-luminal and basal cells and development of treatment resistant breast cancer. We previously reported that transformed MSC with reduced DNA repair contribute to more aggressive mammary tumors. Transformed luminal progenitor cells with altered histone methylation produced aggressive mammary tumors after long latency. The fractions of progenitor and differentiated cells in these tumors also were altered. ER+ tumor cells promoted proliferation and metastasis of tumor derived MSC. H3K27me3 levels were increased in JMJD3 depleted ER+tumor cells. Tumors derived from MMTV-Wnt1 MSC co-transplanted with JMJD3 shRNA transduced ER+ cells demonstrated increased latency with decreased tumor number, volume, and metastasis. Tumors derived from MMTV-Wnt1 MSC co-transplanted with JMJD3 shRNA transduced ER+ cells were classified as poorly differentiated adenocarcinoma by histopathologic analysis. The MSC fraction was reduced in tumors containing JMJD3 shRNA transduced ER+ cells compared to control transduced tumors. The implications of the results presented in this report suggest that while tumor suppressor pathways can inhibit mammary tumorigenesis when DNA damage repair is inhibited, more aggressive clones may eventually evolve via genomic instability with the ability to proliferate and metastasize. Decreased DNA damage repair or altered epigenetic marks can dramatically affect the cellular composition of these tumors, thereby regulating phenotype and outcomes. Paracrine factors secreted by ER+ tumor cells can induce proliferation of tumorigenic MSC, leading to increased genomic instability and metastasis. Epigenetic marks in specific tumor cell populations (MSC vs. ER+) can dramatically alter tumor phenotype and outcome.
Keywords Breast cancer
Decision making
Deoxyribonucleic acids
Dna repair
Estrogen receptor
Histone methylation
Luminal progenitor
Mammary glands
Mammary stem cell
Receptor sites(Physiology)

Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
Corporate Author Illinois Univ. at Chicago.
Document Type Technical report
Title Note Final rept. 1 Mar 2010-28 Feb 2013.
NTIS Issue Number 1319
Contract Number W81XWH-10-1-0081

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader